Indeed, EAAT2 variants have been associated with cerebral palsy in pre-term infants [143], and with grey matter deficits and working memory in schizophrenia, along with altered EAAT1 and EAAT2 mRNA expression seen in some CNS regions of schizophrenic patients [144,145,146]. The gene discussed is SLC1A2; the disease is schizophrenia.